Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Memantine for Enhancement of Rehabilitation Efficacy and Prevention of Major Depressive Disorder in Older Adults

NCT00183729 is registered in ClinicalTrials.gov with Eric Lenze as lead sponsor.

NCT NCT00183729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00183729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Memantine for Enhancement of Rehabilitation Efficacy and Prevention of Major Depressive Disorder in Older Adults
Lead sponsor
Eric Lenze
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2005
Completion date
June 30, 2009
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression